SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Tinnitus - Pipeline Review, H2 2013 Research Report

[February 17, 2014]

Research and Markets: Tinnitus - Pipeline Review, H2 2013 Research Report

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/7r67r9/tinnitus) has announced the addition of the "Tinnitus - Pipeline Review, H2 2013" report to their offering.

'Tinnitus - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Tinnitus, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Tinnitus.

Scope

- A snapshot of the global therapeutic scenario for Tinnitus.

- A review of the Tinnitus products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.


- Coverage of the Tinnitus pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Key Topics Covered:

Introduction

Tinnitus Overview

Therapeutics Development

Pipeline Products for Tinnitus - Overview

Pipeline Products for Tinnitus - Comparative Analysis

Late Stage Products

Clinical Stage Products

Early Stage Products

Unknown Stage Products

Tinnitus - Products under Development by Companies

Tinnitus - Products under Investigation by Universities/Institutes

Tinnitus - Companies Involved in Therapeutics Development

Tinnitus - Therapeutics Assessment

Drug Profiles

esketamine hydrochloride - Drug Profile

Product Description

Mechanism of Action

R&D Progress

neramexane mesylate - Drug Profile

BGG-492 - Drug Profile

JB-004/A - Drug Profile

Drug For Tinnitus - Drug Profile

oxcarbazepine - Drug Profile

gacyclidine - Drug Profile

AUT-00063 - Drug Profile

memantine hydrochloride - Drug Profile

AUT-3 - Drug Profile

YH_Herb - Drug Profile

acamprosate - Drug Profile

Featured News & Press Releases

Appendix

List of Tables

List of Figures

Companies Mentioned

Novartis AG

Merz Pharma GmbH & Co. KgaA

Yuhan Corporation

Auris Medical AG

Otonomy, Inc.

Synphora AB

Flexion Therapeutics, Inc.

Autifony Therapeutics Limited

For more information visit http://www.researchandmarkets.com/research/7r67r9/tinnitus

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.